# A Study to Determine the Metabolism and Excretion of [14C]E2086 in Healthy Male Participants

> **NCT07308236** · PHASE1 · RECRUITING · sponsor: **Eisai Inc.** · enrollment: 10 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** E2086

## Key facts

- **NCT ID:** NCT07308236
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-31
- **Primary completion:** 2026-02-23
- **Final completion:** 2026-02-23
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07308236

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07308236, "A Study to Determine the Metabolism and Excretion of [14C]E2086 in Healthy Male Participants". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07308236. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*